cis-Urocanic acid is a 5-HT2A receptor agonist with high affinity (Kd = 4.6 nM) and functions as an immunomodulator by inducing immunosuppression through binding to the 5-HT2A receptor; it suppresses UV-B-induced secretion of IL-6 and IL-8, decreases caspase-3 activity, and enhances cell viability in human corneal and conjunctival epithelial cells at a concentration of 100 μg/mL.